MicroRNA News and Research

RSS
In genetics, microRNAs (miRNA) are single-stranded RNA molecules of 21-23 nucleotides in length, which regulate gene expression. miRNAs are encoded by genes from whose DNA they are transcribed but miRNAs are not translated into protein (i.e. they are non-coding RNAs); instead each primary transcript (a pri-miRNA) is processed into a short stem-loop structure called a pre-miRNA and finally into a functional miRNA. Mature miRNA molecules are partially complementary to one or more messenger RNA (mRNA) molecules, and their main function is to down-regulate gene expression.
Researchers discover key reason why form of leukemia progresses from chronic phase to blast crisis

Researchers discover key reason why form of leukemia progresses from chronic phase to blast crisis

Second AACR cancer research conference to be hosted in Dead Sea, Jordan

Second AACR cancer research conference to be hosted in Dead Sea, Jordan

Alnylam Pharmaceuticals asks Court to dismiss MIT from any claims for monetary damages in ongoing litigation

Alnylam Pharmaceuticals asks Court to dismiss MIT from any claims for monetary damages in ongoing litigation

Study results of new PCR technology that reports mutations associated with FXS announced

Study results of new PCR technology that reports mutations associated with FXS announced

febit releases updated Geniom Biochip containing 58 new miRNA sequences

febit releases updated Geniom Biochip containing 58 new miRNA sequences

Isis Pharmaceuticals reports revenues of $32.3M for fourth-quarter 2009

Isis Pharmaceuticals reports revenues of $32.3M for fourth-quarter 2009

Researchers find gene regulator that plays key role in DS-AMKL

Researchers find gene regulator that plays key role in DS-AMKL

CPF to partner with ATS to fund Pulmonary Fibrosis research

CPF to partner with ATS to fund Pulmonary Fibrosis research

Regulus Therapeutics, GSK announce new collaboration on microRNA therapeutics targeting microRNA-122

Regulus Therapeutics, GSK announce new collaboration on microRNA therapeutics targeting microRNA-122

Alnylam Pharmaceuticals initiates ALN-RSV01 Phase IIb trial in adult lung transplant patients for RSV infection

Alnylam Pharmaceuticals initiates ALN-RSV01 Phase IIb trial in adult lung transplant patients for RSV infection

Single microRNA exhibits potential to forecast outcomes of MPM

Single microRNA exhibits potential to forecast outcomes of MPM

febit introduces new HybSelector instrument for next-generation resequencing solutions

febit introduces new HybSelector instrument for next-generation resequencing solutions

Asuragen announces agreement to develop and manufacture RNA Control Kits for Affymetrix

Asuragen announces agreement to develop and manufacture RNA Control Kits for Affymetrix

Genzyme and Isis Pharmaceuticals: Phase 3 mipomersen study in heFH patients meets primary endpoint

Genzyme and Isis Pharmaceuticals: Phase 3 mipomersen study in heFH patients meets primary endpoint

Alnylam Pharmaceuticals receives 'Notice of Allowance' from USPTO

Alnylam Pharmaceuticals receives 'Notice of Allowance' from USPTO

Sistemic to develop SistemRNA compound-centric drug discovery technology with closed series A funds

Sistemic to develop SistemRNA compound-centric drug discovery technology with closed series A funds

USPTO issues three patents to Rosetta Genomics

USPTO issues three patents to Rosetta Genomics

10 new kits available for fast and simple isolation of nucleic acids from blood, plasma and serum

10 new kits available for fast and simple isolation of nucleic acids from blood, plasma and serum

Canary Foundation researcher awarded $11.5M NIH POCRC SPORE grant for early detection ovarian cancer research

Canary Foundation researcher awarded $11.5M NIH POCRC SPORE grant for early detection ovarian cancer research

Argonaute binds to microRNA and shuts down protein production

Argonaute binds to microRNA and shuts down protein production

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.